EXPE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Expedia Group Inc (EXPE) is not a strong buy for a beginner investor with a long-term strategy at this time. While the stock has shown a significant price increase recently, the technical indicators suggest it is overbought, and insider selling has surged significantly. Additionally, financial performance shows declining net income and EPS despite revenue growth, which raises concerns about profitability. Analysts maintain neutral ratings with reduced price targets, and there are no strong positive catalysts to justify immediate entry.
The MACD histogram is positive and expanding, indicating bullish momentum. However, the RSI is at 80.583, signaling overbought conditions. Moving averages are converging, and the stock is trading near resistance levels (R1: 242.379, R2: 258.165), suggesting limited upside potential in the short term.
Revenue increased by 11.40% YoY in Q4 2025, showing strong consumer travel demand. Gross margin improved to 84.04%, up 1.47% YoY. The company reported solid Q4 results, with booked room nights and bookings exceeding consensus estimates.
Net income dropped by 31.44% YoY, and EPS decreased by 27.27% YoY, indicating declining profitability. Insider selling has surged by 603.97% over the last month. Analysts have lowered price targets across the board, citing concerns about margin expansion and conservative guidance. The U.S. House Oversight Committee's investigation into the use of AI and consumer data could pose regulatory risks.
In Q4 2025, revenue increased to $3.547 billion, up 11.40% YoY. However, net income dropped to $205 million, down 31.44% YoY, and EPS fell to $1.6, down 27.27% YoY. Gross margin increased to 84.04%, up 1.47% YoY, but the decline in profitability raises concerns.
Analysts maintain neutral ratings with reduced price targets. Recent updates include Mizuho lowering the target to $245 from $270, Citi reducing it to $225 from $281, and BMO Capital raising it slightly to $255 from $250. Analysts acknowledge solid execution but cite concerns about margin expansion, conservative guidance, and balanced risk/reward at current levels.
